Yasmin Side Effects Related Lawsuits

If you believe that you or someone you love may have suffered a stroke or any other injury due to taking Yasmin, the attorneys at Slater Slater Schulman LLP are here to help. Please call us at 1-800-251-6990 or fill out the form below and someone from our office will contact you to discuss your case. The consultation is free of charge.


Yasmin, also known by its generic name Ocella is a birth control pill that contains both drospirenone and ethinyl estradiol. The pill was developed by Berlex Laboratories, and is now being manufactured Bayer Pharmaceuticals. Yasmin is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. Yasmin is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception.

Yasmin Side Effects

Over the past five years there have been over 50 deaths reported to the U.S. Food & Drug Administration (FDA) of women who were taking these prescription drugs.  The most common side effects associated with Yasmin include death, heart attack, cardiac arrhythmia, stroke, pulmonary embolism, kidney failure, gallbladder infection and removal, blood clots and deep vein thrombosis (DVT). The FDA has issued warnings about these drugs in 2003, 2008 and 2009.

Do I have a Yasmin related Lawsuit?

If you or a loved one has taken Yasmin and has experienced one of the dangerous side effects listed above, you may be entitled to compensation. The attorneys at Slater Slater Schulman LLP are dedicated to the representation of plaintiffs in Yasmin lawsuits. Specifically, our firm is currently handling litigation related to Yasmin DVT, Yasmin blood clots and Yasmin pulmonary embolisms.

If you or someone you love has taken Yasmin, you should contact Slater Slater Schulman LLP for a free consultation by filling out the form on this page or by calling (800) 251-6990.

Follow Us on:

Contact Us

Privacy Policy

Please click here to view our privacy policy.